Yung-chieh Tseng
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection.
Journal: Vaccines
Published: March 01, 2024
Monoglycosylated SARS-CoV-2 receptor binding domain fused with HAstem-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza viruses.
Journal: Antiviral research
Published: September 06, 2023
Pilot-scale production of inactivated monoglycosylated split H1N1 influenza virus vaccine provides cross-strain protection against influenza viruses.
Journal: Antiviral research
Published: February 22, 2023
Better influenza vaccines: an industry perspective.
Journal: Journal of biomedical science
Published: December 05, 2019
Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 21, 2019
A common glycan structure on immunoglobulin G for enhancement of effector functions.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 09, 2015
Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 29, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026